EPIC: A phase III trial of ponatinib (PON) versus imatinib (IM) in patients (pts) with newly diagnosed CP-CML.
Jeffrey Howard Lipton
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Charles Chuah
Honoraria - Bristol-Myers Squibb; Novartis
Agnes Guerci-Bresler
No relevant relationships to disclose
Gianantonio Rosti
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
David Simpson
No relevant relationships to disclose
Stephanie Lustgarten
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Nikolaus S. Trede
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Victor M. Rivera
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Tim Clackson
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Frank G. Haluska
Employment or Leadership Position - ARIAD
Consultant or Advisory Role - ARIAD (I)
Stock Ownership - ARIAD
Honoraria - Lia Gore (I)
Research Funding - ARIAD
Michele Baccarani
Consultant or Advisory Role - ARIAD; Novartis
Honoraria - ARIAD; Novartis
Jorge E. Cortes
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Pfizer; Teva
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Francois Guilhot
Consultant or Advisory Role - ARIAD
Honoraria - ARIAD
Andreas Hochhaus
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD; Bristol-Myers Squibb; M2D; Novartis; Pfizer
Timothy P. Hughes
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis
Hagop M. Kantarjian
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Neil P. Shah
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb
Research Funding - ARIAD; Bristol-Myers Squibb
Moshe Talpaz
Consultant or Advisory Role - ARIAD; Novartis
Honoraria - ARIAD
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Michael W.N. Deininger
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Incyte; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Incyte; Novartis
Research Funding - Bristol-Myers Squibb; Celgene; Genzyme; Novartis; YM BioSciences